Portfolio Modifications - 06/10/2025
Novo Nordisk, Google & KWEB.
I’ve always said that fundamentals, research & convictions matter, but beating the market comes down to execution. That’s what these write-ups will be about.
I will share through them every change in my active portfolio - stocks & options, reasonings & plans, before I even hit the buttons. I won’t update DCAs, I will only share my plans & new/closed positions in these write-ups. You can follow the rest directly on savvytrader.
https://savvytrader.com/wealthyreadingspro/active
I also recently opened a Buy & Hodl portfolio on which I will DCA $4,000 every month & focus on buying the best assets I can at the best possible price, 100% focused on fundamentals & valuation, without any active management.
https://savvytrader.com/wealthyreadingspro/buyandhodl
Keep in mind that both portfolios have completely different goals and I can behave very differently on both for the same name - accumulating in the buy & hodl while selling in the active portfolio for example. Different rules apply.
My goal is to deliver alpha over the long term, not just six months under easy market conditions. If/when proven this content is valuable, it will be shared behind a paywall. No rush, though; it’ll stay free until proven valuable.
So here’s the deal: you get full transparency on my trades, right when I make them. If - and only in that case, it brings real & long-term alpha, it’ll be accessible only for a fee. I believe that’s fair enough, but feel free to provide feedback!
Active Portfolio - Sold Google.
Option Portfolio - Sold NVO Dec19'25 $85 Call.
Bought KWEB Jan15'27 35 Call.
Buys.
KWEB Jan15'27 35 Call @ $6.16.
This position is more a leverage play for the Buy & Hold portfolio than a trade, but as it is part of my options account, I have to disclose it here. The justification is shared in my China Investment Thesis & based on the rising buying power of the entire region.
Plus, we have positive news lately with the ongoing tariffs & sanctions talks with the U.S. Any resolution would fuel trust in China as it would mean mutual respect & agreements between the two superpowers & fewer risks of further sanctions.
It doesn’t mean we won’t have volatility, but the calls are dated a year & a half from now, it gives time for volatility to mostly be upward, based on the low valuation of most stocks & improving fundamentals in the region.
I’ll accumulate those calls & shares on the retest of the bullish trendline as usual.
Sells.
NVO Dec19'25 $85 Call @ $7.1.
A short & good ride with 48% returns in 11 days.
I continue to believe that Novo Nordisk is undervalued and has a long way to go, but PA gave what it had to give, and I would rather take my profits and reopen a trade later than hold the pullback.
We have lots of good fundamental news, especially around the new CEO election and the market is bullish about this, but the stock won’t pull a V-shape recovery; those are very, very rare.
I personally expect the market to sell the news or to find reasons to sell the name until we create a real long & beautiful accumulation range, before going back on a bullish trend, which means I wouldn’t be surprised to see the name below $70 in the next few months to print its double bottom.
I’ll be there when it happens. For now, I take those beautiful 48%.
Google @ $180.35.
We had some bullish news on OpenAI which will rent more compute from Google, hence the last few days' green candles, but as often, PA anticipated the new & we were already in to catch it.
I love Google. I believe it is a wonderful company and have said many times that the market was punishing it wrongly, but it still has many challenges ahead, and I do not want to be holding it during such uncertainties. It wasn’t meant to be a long-term position.
So we close it today after 12.3% gains in a bit more than a month, a really respectable trade, as the stock is now retesting the bullish trendline which should act as a resistance now that we are in what seems to be a downtrend.
We might break it & go higher, exactly like Amazon did a few weeks ago. I don’t want to take the risk and am very happy with those 12% returns in a month. There are more opportunities in the market waiting for a healthy pullback - Nebius, Alibaba, KWEB, Transmedics, VG, Sea Limited & Fluor at the top of my mind.